In last trading session, ABVC BioPharma Inc (NASDAQ:ABVC) saw 53020.0 shares changing hands with its beta currently measuring 0.71. Company’s recent per share price level of $0.51 trading at $0.0 or 0.83% at ring of the bell on the day assigns it a market valuation of $6.62M. That closing price of ABVC’s stock is at a discount of -380.39% from its 52-week high price of $2.45 and is indicating a premium of 19.61% from its 52-week low price of $0.41. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.11 million shares which gives us an average trading volume of 143.46K if we extend that period to 3-months.
For ABVC BioPharma Inc (ABVC), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ABVC BioPharma Inc (NASDAQ:ABVC) trade information
Upright in the green during last session for gaining 0.83%, in the last five days ABVC remained trading in the red while hitting it’s week-highest on Thursday, 11/21/24 when the stock touched $0.51 price level, adding 13.56% to its value on the day. ABVC BioPharma Inc’s shares saw a change of -56.02% in year-to-date performance and have moved -10.08% in past 5-day. ABVC BioPharma Inc (NASDAQ:ABVC) showed a performance of -27.39% in past 30-days. Number of shares sold short was 0.19 million shares which calculate 0.7 days to cover the short interests.
ABVC BioPharma Inc (ABVC) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 12.78% during past 5 years.
ABVC BioPharma Inc (NASDAQ:ABVC)’s Major holders
Insiders are in possession of 22.93% of company’s total shares while institution are holding 3.01 percent of that, with stock having share float percentage of 3.91%. Investors also watch the number of corporate investors in a company very closely, which is 3.01% institutions for ABVC BioPharma Inc that are currently holding shares of the company.
